Clovis Oncology
CLVS
#10899
Rank
NZ$20.56 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-94.96%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -NZ$0.35 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2021 the company made an earning of -NZ$0.41 Billion, an increase over its 2020 earnings that were of -NZ$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.35 Billion-16.5%
2021 -NZ$0.41 Billion-32.64%
2020 -NZ$0.61 Billion-9.06%
2019 -NZ$0.67 Billion7.49%
2018 -NZ$0.62 Billion4.42%
2017 -NZ$0.6 Billion-8.83%
2016 -NZ$0.65 Billion-0.4%
2015 -NZ$0.66 Billion140.82%
2014 -NZ$0.28 Billion86.64%
2013 -NZ$0.15 Billion19.53%
2012 -NZ$0.13 Billion
2010 -NZ$46.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B-12,049.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.50 B-4,971.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.43 B-2,848.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.37 B-14,416.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.61 B-6,845.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-277.36%๐Ÿ‡บ๐Ÿ‡ธ USA